| Literature DB >> 31106063 |
Bo Zhang1, Jie Zhou1, Qiang Li1,2, Bingcheng Gan1, Weihong Peng1, Xiaoping Zhang3, Wei Tan1, Lin Jiang1, Xiaolin Li1.
Abstract
BACKGROUND: As a metal-enriched edible fungus, Ganoderma lucidum is capable of adsorbing manganese effectively. And the manganese ion is demonstrated to play an important role in the synthesis of manganese peroxidase (Mnp) and other physiological activities during G. lucidum growth. Recently, the influence of manganese on the metabolites of G. lucidum fruiting bodies can be revealed through metabonomics technique.Entities:
Keywords: Ganoderma lucidum; Growth; LC-MS method; Manganese; Metabolism
Year: 2019 PMID: 31106063 PMCID: PMC6500383 DOI: 10.7717/peerj.6846
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
The tested physiological indexes of Ganoderma lucidum in different treatments.
| NO. | MGR (mm/d) | Yield (g) | MnP (nmol/min/g) | TP (%) | TT (%) | TM (mg/kg) |
|---|---|---|---|---|---|---|
| CK | 5.70 ± 0.19b | 27.30 ± 1.79d | 30.65 ± 0.32f | 2.13 ± 0.12a | 2.46 ± 1.32a | 7.20 ± 0.30e |
| Mn50 | 6.15 ± 0.15a | 34.00 ± 2.70bcd | 46.87 ± 1.14e | 2.11 ± 0.30a | 3.71 ± 0.37a | 11.97 ± 0.06c |
| Mn100 | 6.18 ± 0.21a | 32.10 ± 2.20bcd | 60.38 ± 0.41c | 1.13 ± 0.18b | 3.17 ± 1.72a | 10.30 ± 0.10d |
| Mn150 | 6.15 ± 0.09a | 36.60 ± 1.94ab | 67.83 ± 1.29b | 1.28 ± 0.03b | 3.35 ± 0.51a | 10.43 ± 0.12d |
| Mn200 | 5.95 ± 0.12ab | 27.90 ± 2.98cd | 82.40 ± 1.33a | 1.19 ± 0.17b | 3.57 ± 0.24a | 13.13 ± 0.15b |
| Mn250 | 6.00 ± 0.07ab | 35.20 ± 1.85bc | 52.69 ± 1.71d | 1.44 ± 0.48b | 3.05 ± 0.32a | 13.30 ± 0.00b |
| Mn300 | 5.85 ± 0.09ab | 38.80 ± 1.26ab | 56.83 ± 1.73cd | 1.21 ± 0.27b | 2.64 ± 0.80a | 13.00 ± 0.50b |
| Mn350 | 5.98 ± 0.11ab | 42.60 ± 2.95a | 71.37 ± 2.28b | 1.21 ± 0.04b | 2.95 ± 0.45a | 15.37 ± 0.45a |
Notes:
NO., substrates with different manganese ion concentration; MGR, mycelial growth rate; Yield, the dry yield per bag; MnP, the activity of manganese peroxidase determined with fresh weight; TP, the total content of polysaccharides in mature fruiting bodies; TT, the content of triterpenoids in mature fruiting bodies; TM, the total content of manganese in mature fruiting bodies. CK, the control group without MnSO4 addition; Mn50, the treatment group with 50 mg/kg MnSO4 addition; Mn100, the treatment group with 100 mg/kg MnSO4 addition; Mn150, the treatment group with 150 mg/kg MnSO4 addition; Mn200, the treatment group with 200 mg/kg MnSO4 addition; Mn250, the treatment group with 250 mg/kg MnSO4 addition; Mn300, the treatment group with 300 mg/kg MnSO4 addition; Mn350, the treatment group with 350 mg/kg MnSO4 addition.
Data with different lower-case letters display significant differences (p-value < 0.05) by LSD method of one-way ANOVA. MGR, Yield, MnP, and TP are with more than three replicates.
Figure 1LC-MS base peak chromatograms of CK (in blue) and Mn (in red) samples in positive (A) and negative ionization mode (B).
CK, the control group without MnSO4 addition; Mn, the treatment group with 200 mg/kg MnSO4 addition. X-axis represents the retention time, and Y-axis represents base peak intensity. The figure displays the detected peaks in positive (A) and negative (B) ionization modes. The strongly detected molecules of metabolites in G. lucidum fruiting bodies exhibited a decrease or an increase between the control and the Mn-treated samples.
Figure 2PLS-DA score plot.
CK, the control group without MnSO4 addition; Mn, the treatment group with 200 mg/kg MnSO4 addition. The control samples were in blue and the Mn-treated samples in red. (A) Positive ionization mode, R2X[1] = 0.157, R2X[2] = 0.156, Ellipse: Hotelling’s T2 (95%); (B) negative ionization mode, R2X[1] = 0.183, R2X[2] = 0.136, Ellipse: Hotelling’s T2 (95%). PLS-DA analysis is to distinguish the different metabolites between the Mn-treated and control samples of G. lucidum.
Figure 3Investigation of differential metabolites comparing the Mn-treated samples to the control.
CK, the control group without MnSO4 addition; Mn, the treatment group with 200 mg/kg MnSO4 addition. X-axis represents the samples, and Y-axis represents number of DE metabolites. The up-regulated metabolites are in red, and the down-regulated are in blue.
Significantly differential metabolites of Ganoderma lucidum between two treatments.
| Putative identification | m/z | rt (s) | RMM | MF | PT | log2fc(Mn/CK) | |
|---|---|---|---|---|---|---|---|
| Chavicol | 135.08 | 775.06 | 134.18 | C9H10O | [M+H]+ | 0.69 | 0.0013 |
| Palmitoylethanolamide | 300.29 | 882.81 | 299.49 | C18H37NO2 | [M+H]+ | 1.01 | 0.0059 |
| D-gluconate | 195.05 | 101.26 | 196.06 | C6H12O7 | [M−H]− | 0.92 | 0.0126 |
| Diosmin | 610.17 | 358.73 | 608.54 | C28H32O15 | [M+H]+ | 1.86 | 0.0142 |
| 122.10 | 769.89 | 121.18 | C8H11N | [M+H]+ | 0.95 | 0.0208 | |
| Benzaldehyde | 107.05 | 775.05 | 106.12 | C7H6O | [M+H]+ | 0.68 | 0.0233 |
| 2,5-Dihydroxybenzaldehyde | 137.02 | 428.47 | 138.12 | C7H6O3 | [M−H]− | −2.29 | 0.0248 |
| Inosine | 267.07 | 254.89 | 268.23 | C10H12N4O5 | [M−H]− | 2.02 | 0.0277 |
| 3-Methylcrotonyl-CoA | 851.40 | 743.50 | 849.63 | – | [M+H]+ | 1.71 | 0.0310 |
| Cellotetraose | 667.23 | 82.59 | 666.58 | C24H42O21 | [M+H]+ | 1.61 | 0.0313 |
| N(ω),N(ω)-dimethyl-L-arginine | 203.15 | 84.51 | 202.25 | C8H18N4O2 | [M+H]+ | −0.80 | 0.0347 |
| L-(+)-Maltose monnhydrate | 360.15 | 106.87 | 360.31 | – | [M+H]+ | 1.35 | 0.0394 |
| Creatine | 261.13 | 358.99 | 131.13 | C4H9N3O2 | [M−H]− | −1.05 | 0.0423 |
| Choline | 104.11 | 236.68 | 103.10 | C5H13NO | [M+H]+ | −1.10 | 0.0430 |
| 5-S-methyl-5-thioadenosine | 298.10 | 310.62 | 297.33 | C11H15N5O3S | [M+H]+ | 0.85 | 0.0431 |
| Nipecotic acid | 130.09 | 65.12 | 129.08 | C6H11NO2 | [M+H]+ | −0.83 | 0.0490 |
Note:
m/z, mass charge ratio; rt, retention time; RMM, relative molecular mass; MF, molecular formula; PT, precursor type.
Figure 4Heat map of significantly differential metabolites.
CK, the control group without MnSO4 addition; Mn, the treatment group with 200 mg/kg MnSO4 addition. There are six duplications in each treatment. The samples were subject to bidirectional clustering analysis using the R package Pheatmap based on the euclidean distance and complete linkage clustering. The up-expressed metabolites are colored in red and the down-regulated metabolites in green, respectively. The heat map presents and groups all the significantly differential metabolites.
Figure 5Correlation heat map of differential metabolites.
The blank squares showed no relevance between differential metabolites based on the statistical test (p-value > 0.05). The squares with color markings showed mutual promotion or inhibition relationships between differential metabolites (p-value < 0.05).
Metabolic pathways information.
| KEGG | Total | Expected | Hits | Raw | −log( | FDR | Impact |
|---|---|---|---|---|---|---|---|
| Pentose phosphate pathway | 18 | 0.27 | 1 | 0.24 | 1.42 | 1 | 0 |
| Glycerophospholipid metabolism | 26 | 0.39 | 1 | 0.33 | 1.10 | 1 | 0.0112 |
| Cysteine and methionine metabolism | 33 | 0.50 | 1 | 0.40 | 0.91 | 1 | 0.0108 |
| Purine metabolism | 60 | 0.91 | 1 | 0.61 | 0.49 | 1 | 0.0059 |
Note:
Total, the total number of metabolites in targeted metabolic pathway; Expected, one parameter; Hits, the actually matched number from the user uploaded data; Raw p, the original p-value calculated from the enrichment analysis; FDR, the p-value adjusted using False Discovery Rate; Impact, the pathway impact value calculated from pathway topology analysis.